Patents by Inventor Bernhard Radlwimmer

Bernhard Radlwimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of brain tumors
    Patent number: 9241993
    Abstract: Described is a compound capable of reducing or inhibiting (a) the biological activity of branched-chain-aminotranferase-1 (BCAT1) or (b) the expression of the gene encoding BCAT1 for use in a method of treating a neoplasia. A preferred compound is 1-(aminomethyl) cyclohexaneacetic acid (gabapentin).
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: January 26, 2016
    Assignee: Deutsches Krebsforschungszentrum
    Inventors: Bernhard Radlwimmer, Martje Toenjes, Sebastian Barbus, Peter Lichter
  • Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors
    Publication number: 20150374800
    Abstract: Described is a compound capable of reducing or inhibiting (a) the biological activity of branched-chain-aminotrans-ferase-1 (BCATI) or (b) the expression of the gene encoding BCATI for use in a method of treating a neoplasia. A preferred compound is 1-(aminomethyl)cyclohexaneacetic acid (gabapentin).
    Type: Application
    Filed: June 26, 2015
    Publication date: December 31, 2015
    Inventors: Bernhard RADLWIMMER, Martje TOENJES, Sebastian BARBUS, Peter LICHTER
  • Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of brain tumors
    Patent number: 9114132
    Abstract: Described is a compound capable of reducing or inhibiting (a) the biological activity of branched-chain-aminotranferase-1 (BCAT1) or (b) the expression of the gene encoding BCAT1 for use in a method of treating a neoplasia. A preferred compound is 1-(aminomethyl) cyclohexaneacetic acid (gabapentin).
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: August 25, 2015
    Assignee: Deutsches Krebsforschungszentrum
    Inventors: Bernhard Radlwimmer, Martje Toenjes, Sebastian Barbus, Peter Lichter
  • Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors
    Publication number: 20130310545
    Abstract: Described is a compound capable of reducing or inhibiting (a) the biological activity of branched-chain-aminotranferase-1 (BCAT1) or (b) the expression of the gene encoding BCAT1 for use in a method of treating a neoplasia. A preferred compound is 1-(aminomethyl) cyclohexaneacetic acid (gabapentin).
    Type: Application
    Filed: January 27, 2012
    Publication date: November 21, 2013
    Applicant: Deutsches Krebsforschungszentrum
    Inventors: Bernhard Radlwimmer, Martje Toenjes, Sebastian Barbus, Peter Lichter